Topiramato Teva 100 mg Film-Coated Tablets
This medicine is subject to additional monitoring, which will speed up the detection of new information about its safety. You can contribute by reporting any adverse effects you may experience. The final part of section 4 includes information on how to report these adverse effects.
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
Topiramato Teva belongs to a group of medicines called “anti-epileptic medicines”. It is used for:
Prevention of migraines
Treatment of epilepsy
Make sure you read the patient leaflet that you will receive from your doctor or scan the QR code to obtain it (see section 6 “Other sources of information”).
A patient leaflet is provided with the packaging of Topiramato Teva to remind you of the risks during pregnancy.
If you are unsure whether anything above applies to you, consult your doctor or pharmacist before using Topiramato Teva.
Consult your doctor or pharmacist before starting to take Topiramato Teva
If you are unsure whether anything above applies to you, consult your doctor before using topiramate.
If you have epilepsy, it is essential not to stop taking your medication without consulting your doctor first.
It is essential not to stop taking your medication without consulting your doctor first.
You should consult your doctor before taking any other medication containing topiramate that is given as an alternative to Topiramato Teva.
You may lose weight if you take Topiramato Teva, so your weight should be monitored regularly while you are taking this medicine. If you lose too much weight or if a child taking this medicine does not gain enough weight, you should consult your doctor.
A small number of people being treated with antiepileptic drugs such as Topiramato Teva have had thoughts of harming themselves or taking their own lives. If you ever have these thoughts, contact your doctor immediately.
Topiramate may cause severe skin reactions. Contact your doctor immediately if you develop a skin rash and/or blisters (see also section 4 “Possible side effects”).
Topiramate may cause high levels of ammonia in the blood (seen in blood tests) which may cause a change in brain function, especially if you are also taking a medicine called valproic acid or valproate sodium. Since this can be a serious condition, talk to your doctor immediately if you experience any of the following symptoms (see also section 4 “Possible side effects”):
You may be at increased risk of developing these symptoms at higher doses of topiramate.
Other medicines and Topiramato Teva
Inform your doctor or pharmacist if you are using or have recently used other medicines, including those bought without a prescription, vitamins, or herbal remedies. Topiramato Teva and certain other medicines may affect each other. Sometimes, the dose of one or both medicines may need to be adjusted.
Especially inform your doctor or pharmacist if you are taking:
Tell your doctor if you change your menstrual bleeding while taking hormonal contraceptives and topiramate. You may experience irregular bleeding. In this case, continue taking the hormonal contraceptives and inform your doctor.
Keep a list of all the medicines you take. Show this list to your doctor and pharmacist before using Topiramato Teva.
Other medicines that you should consult your doctor or pharmacist about include other antiepileptic medicines, risperidone, lithium, hydrochlorothiazide, metformin, pioglitazone, glibenclamide, amitriptyline, propranolol, diltiazem, venlafaxine, flunarizine, St. John's Wort (Hypericum perforatum) (a herbal preparation used to treat depression), warfarin used to prevent blood clotting.
If you are unsure whether anything above applies to you, consult your doctor or pharmacist before taking Topiramato Teva.
You can take Topiramato Teva with or without food. Drink plenty of liquid during the day to prevent kidney stone formation while taking Topiramato Teva. You should avoid drinking alcohol while taking Topiramato Teva.
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Important advice for fertile women:
Topiramate may cause harm to a baby during pregnancy. If you are a fertile woman, consult your doctor about other possible treatments. Visit your doctor to review your treatment and discuss the risks at least once a year.
Prevention of migraines
Treatment of epilepsy
Risks of topiramate during pregnancy (regardless of the condition for which topiramate is used) are as follows:
There is a risk of harm to a baby during pregnancy if topiramate is used during pregnancy.
Need for contraceptive methods in fertile women:
Use of Topiramato Teva in girls:
If you are the parent/caregiver of a girl treated with topiramate, you should consult your doctor immediately once your daughter experiences her first menstrual period (menarche). The doctor will inform you about the risks to a baby during pregnancy due to exposure to topiramate during pregnancy and about the need to use highly effective contraceptive methods.
If you want to become pregnant while taking Topiramato Teva:
Your doctor may also refer you to another specialist.
If you have become pregnant or think you may be pregnant while taking Topiramato Teva:
Your doctor may also refer you to another specialist.
Make sure you read the patient leaflet that you will receive from your doctor. The patient leaflet is also available by scanning a QR code; see section 6 “Other sources of information”. A patient leaflet is provided with the packaging of Topiramato ratiopharm to remind you of the risks of topiramate during pregnancy.
Breastfeeding
The active ingredient of Topiramato Teva (topiramate) passes into breast milk. There have been reports of effects in breastfed babies of mothers treated with topiramate, including diarrhea, feeling sleepy, feeling irritable, and low weight gain. Therefore, your doctor will discuss with you whether to stop breastfeeding or whether to stop taking Topiramato Teva. Your doctor will take into account the importance of the benefits for the mother and the risk to the baby.
Mothers who are breastfeeding and taking Topiramato Teva should inform their doctor as soon as possible if the baby experiences anything unusual.
Topiramato Teva contains lactose and sodium
This medicine contains lactose. If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will usually start with a low dose of topiramato and gradually increase your dose to find the best one for you.
Girls and fertile women:
Topiramato treatment should begin and continue under the supervision of a doctor experienced in treating epilepsy or migraine. Visit your doctor at least once a year to review your treatment.
If you take more Topiramato Teva than you should
You may experience an overdose if you are taking another medication with topiramato.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, Teléfono 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Topiramato Teva
If you interrupt treatment with Topiramato Teva
Do not stop treatment without your doctor's instructions. Your symptoms may return. If your doctor decides that you should stop taking this medication, they will gradually reduce your dose over several days.
If you have any other questions about using this medication, ask your doctor or pharmacist.
The frequency of the possible side effects listed below is defined using the following convention:
Very common side effects that include:
Common side effects that include:
Uncommon side effects that include:
Rare side effects that include:
Side effects of unknown frequency:
Children and adolescents:
Generally, side effects observed in children are similar to those observed in adults, but the following side effects may be more frequent in children than in adults:
Other side effects that may appear in children are:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Learning problems
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Store at a temperature below30°C.
Store in the outer packaging to protect it from humidity.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Topiramato Teva
The active ingredient is topiramate.
Topiramato Teva 100 mg: each tablet contains 100 mg of topiramate.
The other components are:
Core: lactose monohydrate, pregelatinized cornstarch, microcrystalline cellulose, sodium carboxymethyl starch (type A), anhydrous colloidal silica, magnesium stearate.
Coating: maltodextrin, hypromellose (E464), titanium dioxide (E171), yellow iron oxide (E172), black iron oxide (E172), and macrogol 4000.
Appearance of the product and contents of the packaging
Topiramato Teva 100 mg is presented in packaging containing 60 film-coated tablets of yellow color, in capsule form. One side is scored and engraved with “T” and “100” on both sides of the score. The other side is smooth.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Teva Pharma, S.L.U.
C/ Anabel Segura, 11, Edificio Albatros B, 1st floor,
Alcobendas, 28108 Madrid
Spain
Responsible for manufacturing
Teva Operations Poland Sp. z o.o.
80 Mogilska str.
31-546 Krakow
Poland
O
Teva Pharmaceutical Works Private Limited Company
Pallagi ut 13, Debrecen, H-4042
Hungary
Date of the last review of this leaflet:February 2024
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/)
The latest approved information (patient guide) on this medicine is available by scanning the following QR code with a smartphone. The same information is also available on the following website (URL):https://cima.aemps.es/cima/DocsPub/16/3252
[QR code]
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.